一期眶减压联合术中眼外肌松弛治疗甲状腺相关眼病:一项随机对照试验
该前瞻性单盲随机对照试验纳入38例甲状腺相关眼病(TAO)患者,比较一期内镜眶减压联合术中内直肌松弛定位(A组19例)与分期手术(B组19例)的疗效与安全性。两组术后最佳矫正视力、视野平均偏差、眼球突出度和眼压较术前均显著改善,组间无显著差异;眼球运动与感觉成功率组间亦无显著差异。结论认为一期手术可同时缓解眼球突出和复视,效果与分期手术相当,并减少手术次数及相关风险。
要点
- 一期眶减压联合术中内直肌松弛定位与分期手术治疗TAO相关内斜视,术后疗效指标组间无显著差异。
- 两组术后最佳矫正视力、视野平均偏差、眼球突出度和眼压较术前均显著改善。
- A组运动成功率68.40%(13/19)、感觉成功率78.95%(15/19),B组分别为73.70%(14/19)和84.21%(16/19),组间无显著差异。
核心结论
- 一期手术可同时缓解眼球突出和复视,效果与分期手术相当。
- 该治疗策略可为患者提供更大的治疗便利,减少总体手术次数及其相关风险。
研究设计与样本
- 前瞻性、单盲、随机对照试验,设置于温州医科大学附属眼视光医院。
- 38例符合研究要求的TAO患者纳入研究。
- A组19例接受一期手术,平均年龄52.32±9.90岁,男12例、女7例。
- B组19例接受分期手术,平均年龄52.53±8.49岁,男9例、女10例。
- 比较两组术前与术后最佳矫正视力、视野平均偏差、Hertel眼球突出计测量值、眼压、偏斜度、眼球运动和复视。
主要发现
- A组8例(42.11%)行单侧眶减压、11例行双侧眶减压;B组19例均行双侧眶减压。
- 术后较术前,最佳矫正视力A组0.09±0.15 logMAR、B组0.04±0.08 logMAR,视野平均偏差A组-2.73±3.36 dB、B组-1.82±3.75 dB,眼球突出度A组16.23±2.58 mm、B组17.04±2.70 mm,眼压A组16.23±4.49 mmHg、B组17.24±4.14 mmHg,两组均显著改善,组间无显著差异。
- 每组各有8例(42.11%)手术针对单一内直肌,其余11例针对两条内直肌。
- A组运动成功率68.40%(13/19)、感觉成功率78.95%(15/19);B组分别为73.70%(14/19)和84.21%(16/19)。
- 两组在术后残余斜视、立体视觉改善或成功率方面无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To gauge the efficacy and safety of performing a one-stage endoscopic orbital decompression procedure combined with the intraoperative relaxed medial rectus muscle (MR) positioning technique as a means of treating esotropia associated with thyroid-associated ophthalmopathy (TAO). DESIGN: Prospective, single-blind, randomized controlled trial. SETTING: Eye Hospital of Wenzhou Medical University. METHODS: 38 TAO patients fulfilled the study requirements. The patients in Group A (n=19; mean age 52.32 ± 9.90 years; 12 males, 7 females) underwent a one-stage surgical procedure, whereas the patients in Group B (n=19; mean age 52.53 ± 8.49 years; 9 males, 10 females) underwent staged surgery. Preoperative and postoperative best-corrected visual acuity (BCVA), visual field mean deviation (MD), Hertel exophthalmometry, intraocular pressure (IOP), deviation, ocular motility, and diplopia were compared between these two groups. RESULTS: Of the patients in Group A, 8 (42.11%) underwent unilateral orbital decompression and 11 underwent bilateral decompression, while all 19 patients in Group B underwent bilateral decompression. Both groups exhibited significant improvements in postoperative BCVA (Group A 0.09 ± 0.15 logMAR, Group B 0.04 ± 0.08 logMAR), MD of visual field (Group A -2.73 ± 3.36 dB, Group B -1.82 ± 3.75 dB), proptosis (Group A 16.23 ± 2.58 mm, Group B 17.04 ± 2.70 mm), and IOP (Group A 16.23 ± 4.49 mmHg, Group B 17.24 ± 4.14 mmHg) when comparing postoperative values to preoperative levels, while there were no significant differences between these groups. In each group, 8 patients (42.11%) underwent surgical procedures targeting one single MR, whereas the remaining 11 in each group underwent surgery on two MRs. The respective primary motor and sensory success rates in Group A were 68.40% (13/19) and 78.95% (15/19), whereas those in Group B were 73.70% (14/19) and 84.21% (16/19), with no significant differences between these groups in terms of postoperative residual strabismus, stereoscopic vision improvements, or success rates. CONCLUSION: These results demonstrate that a one-stage surgical procedure can simultaneously alleviate proptosis and diplopia while achieving outcomes comparable to those achieved through staged surgery. This treatment strategy can thus provide patients with greater therapeutic convenience, decreasing the overall number of surgical procedures and their attendant risks.
引用
- Chen L, Sun Y, Liu W, et al. One-Stage Orbital Decompression Combined With Intraoperative Muscle Relaxation for TAO: A Randomized Controlled Trial. Am J Ophthalmol. 2024. PMID: 39551367. doi:10.1016/j.ajo.2024.11.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。